FDA Grants Accelerated Approval to OJEMDA as First Targeted Therapy for Pediatric Low-Grade Glioma with BRAF Alterations
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to tovorafenib, marketed...
Knowledge and News for the Global Fight Against Cancer.
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to tovorafenib, marketed...
A groundbreaking fusion of 3D printing technology, advanced stem cell biology, and the creation of...
A groundbreaking study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center offers...
Researchers at the University of Oxford have created a new calculator that estimates a person’s...
A comprehensive, randomized controlled trial, one of the most extensive and rigorously designed to date,...
In a landmark study that challenges long-held assumptions about the safety of everyday over-the-counter medications,...
The Biological Challenge of Ewing Sarcoma Ewing sarcoma is the second most common primary bone...
These pivotal findings arrive at a crucial juncture for global healthcare systems, grappling with an...
This groundbreaking discovery, detailed in a recent publication in the Proceedings of the National Academy...
In a development that could redefine the foundations of preventative medicine, a multidisciplinary team led...